Connection

Co-Authors

This is a "connection" page, showing publications co-authored by ANDREW CIVITELLO and LEO SIMPSON.
Connection Strength

0.710
  1. Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock: bridge to myectomy. Ann Thorac Surg. 2012 Mar; 93(3):978-80.
    View in: PubMed
    Score: 0.104
  2. Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J. 2009; 36(5):494-5.
    View in: PubMed
    Score: 0.084
  3. Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance. Cardiovasc Drugs Ther. 2024 Aug 20.
    View in: PubMed
    Score: 0.062
  4. Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 Sep; 10(9):2049-2058.
    View in: PubMed
    Score: 0.062
  5. Predictors and Impact of Prolonged Vasoplegia After Continuous-Flow Left Ventricular Assist Device Implantation. JACC Adv. 2024 May; 3(5):100916.
    View in: PubMed
    Score: 0.060
  6. The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2022 02 21; 34(3):470-477.
    View in: PubMed
    Score: 0.052
  7. Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
    View in: PubMed
    Score: 0.045
  8. Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device. Ann Thorac Surg. 2020 06; 109(6):e439-e440.
    View in: PubMed
    Score: 0.044
  9. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
    View in: PubMed
    Score: 0.040
  10. Incidence, Predictors, and Significance of?Ventricular Arrhythmias in Patients With?Continuous-Flow Left Ventricular Assist Devices: A 15-Year Institutional Experience. JACC Clin Electrophysiol. 2018 02; 4(2):257-264.
    View in: PubMed
    Score: 0.039
  11. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017 Jan; 48(1):27-34.
    View in: PubMed
    Score: 0.035
  12. Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the Fontan procedure. Tex Heart Inst J. 2015 Feb; 42(1):40-3.
    View in: PubMed
    Score: 0.032
  13. Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices. J Heart Lung Transplant. 2014 May; 33(5):470-7.
    View in: PubMed
    Score: 0.030
  14. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.